Sir John Bell, FRS

Professor Sir John Bell

President, EIT Oxford
Co-CEO, EIT Global
EIT Faculty
Principal, GHSC

Prof Sir John Bell leads multi-disciplinary teams at EIT Oxford – a major new interdisciplinary research and development facility that will support EIT’s mission to develop and deploy technology in pursuit of solving humanity’s most challenging and enduring problems.

Sir John served as Regius Professor of Medicine at the University of Oxford from 2002 to 2024. His extensive research interests span the areas of autoimmune disease, immunology and genetics. He was crucial in creating Genomics England, UK Biobank and Our Future Health. He has advised multiple Ministers and Prime Ministers in the UK government.

He was President of the Academy of Medical Sciences from 2006 to 2011 and elected Fellow of the Royal Society and honorary Fellow of the Royal Academy of Engineering.

Holder of prominent roles during the Covid epidemic, enabling the development of the testing platforms for lateral flow tests and helping to initiate the molecular testing program nationally, Prof Bell played a major role in the development and roll out of the Oxford-AstraZeneca Covid-19 vaccine.

He was appointed Knight Grand Cross of the Order of the British Empire (GBE) in the 2015 New Year Honours for services to medicine, medical research and the life science industry. He was appointed Companion of Honour (CH) in 2023 for services to medicine, medical research, the life science industry and public health.